Caspase-3 (Casp3) in Mus musculus is a cysteine protease that serves as a pivotal executioner of apoptosis, orchestrating the controlled demolition of cells through targeted protein cleavage (pmc.ncbi.nlm.nih.gov). Synthesized as an inactive proenzyme, Casp3 is activated by initiator caspases (e.g. caspase-8 or caspase-9) via proteolytic processing into large (≈17 kDa) and small (≈12 kDa) subunits that assemble into the active heterotetrameric enzyme (pmc.ncbi.nlm.nih.gov). Once active, Casp3 cleaves a broad spectrum of substrates – it is noted as a “promiscuous” enzyme with hundreds of targets – driving classical apoptotic events such as DNA fragmentation, chromatin condensation, membrane blebbing, and phosphatidylserine exposure (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In the context of development, Casp3-mediated apoptosis is indispensable for proper tissue morphogenesis; mice lacking Casp3 show impaired programmed cell death and developmental abnormalities (especially in the nervous system) due to failure to eliminate excess cells (pmc.ncbi.nlm.nih.gov). Beyond apoptosis, emerging evidence links Casp3 to diverse biological roles including regulation of differentiation, tissue remodeling, and immune signaling (pmc.ncbi.nlm.nih.gov). For example, Casp3 can trigger a form of pro-inflammatory cell death (pyroptosis) by activating gasdermin-E pores in certain contexts (pubmed.ncbi.nlm.nih.gov), and it cleaves key antiviral signaling proteins to dampen immune activation during apoptosis (pubmed.ncbi.nlm.nih.gov). Casp3 predominantly resides in the cytosol of healthy cells (pmc.ncbi.nlm.nih.gov), with a subset localized to mitochondria and potentially nucleus, and upon activation it translocates to nuclear and other compartments to cleave substrates wherever they reside (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This report details Casp3’s molecular function, activation mechanism, subcellular localization, and the major biological processes it influences in mice. We distinguish Casp3’s well-established core functions from context-specific or pleiotropic roles, guiding Gene Ontology (GO) annotations to reflect the most robustly supported activities while cautioning against over-extension of annotations beyond the evidence. Key recent literature (2019–2024) is highlighted to ensure up-to-date understanding of Casp3’s functions and regulatory interactions.
Protease Activity and Substrate Specificity: Caspase-3 is a thiol-dependent endopeptidase that recognizes and cleaves peptide bonds C-terminal to aspartate residues in substrate proteins (pmc.ncbi.nlm.nih.gov). It belongs to the cysteine-aspartic protease family (“caspases”) and is often referred to as a cysteine-type peptidase with aspartate specificity (EC 3.4.22.56). Casp3 typically targets substrates containing a conserved tetrapeptide motif ending in Asp; a classic example is the DEVD↓ motif (Asp-Glu-Val-Asp↓) which is efficiently cleaved and forms the basis of many Casp3 synthetic substrates and inhibitors (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). In fact, Casp3 exhibits broad specificity, capable of cleaving a wide array of caspase recognition sequences – it has been shown to cleave substrates preferred by other caspases (e.g. sequences for caspase-6, -7, -8, etc.), albeit with varying efficiencies (pmc.ncbi.nlm.nih.gov). This broad substrate profile underlies its central role in dismantling diverse cellular components during apoptosis. Key physiological substrates of Casp3 include structural and repair proteins such as poly(ADP-ribose) polymerase-1 (PARP1, a DNA repair enzyme cleaved early in apoptosis), nuclear lamins (cleavage leads to nuclear envelope breakdown), the inhibitor of caspase-activated DNase (ICAD; cleavage releases CAD endonuclease to fragment DNA), cytoskeletal proteins (e.g. gelsolin, fodrin, etc., contributing to cytoskeletal collapse), and numerous signaling proteins (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Through these cleavages, Casp3 executes the apoptotic program.
Activation Mechanism: Caspase-3 is produced as an inactive pro-caspase (32 kDa zymogen) that must be proteolytically processed to become active (pmc.ncbi.nlm.nih.gov). Activation typically occurs via the initiator caspases of the apoptotic pathways: in the extrinsic (death receptor) pathway, caspase-8 (or -10 in humans) cleaves procaspase-3; in the intrinsic (mitochondrial) pathway, caspase-9 (within the Apaf-1 apoptosome complex) cleaves procaspase-3 (pmc.ncbi.nlm.nih.gov). The procaspase-3 molecule is cleaved at two aspartate sites, removing the N-terminal prodomain and separating the large and small subunits. These subunits then dimerize, and two such heterodimers associate to form the active caspase-3 enzyme (p17/p12)_2 (pmc.ncbi.nlm.nih.gov). The requirement for aspartate-specific cleavage ensures that Casp3 activation is tightly controlled by upstream caspases. Notably, once active, Casp3 can further amplify the cascade by cleaving and activating other effector caspases (e.g. caspase-7 and caspase-6) and even cleaving initiator caspases themselves in feedback loops (pmc.ncbi.nlm.nih.gov). This amplifying capacity cements Casp3’s role as a point-of-no-return in apoptosis. Casp3’s activity is calcium-independent (unlike some non-caspase proteases) and is primarily regulated by proteolytic activation and inhibition by dedicated proteins rather than by cofactors.
Regulation and Inhibition: In healthy cells, procaspase-3 is kept in check by the lack of upstream activating signals and by endogenous inhibitors. One major class of regulators are the Inhibitor of Apoptosis Proteins (IAPs). XIAP (X-linked IAP) binds directly to active caspase-3 and -7 via its BIR2 domain and an N-terminal linker, occluding the caspase active site and thereby blocking substrate access (pmc.ncbi.nlm.nih.gov). This potent inhibition is relieved when mitochondrial pro-apoptotic factors like Smac/DIABLO are released; Smac binds XIAP and neutralizes it, freeing Casp3 to act. Another giant IAP, BIRC6 (also known as Bruce), has been shown to bind caspase-3 and facilitate its ubiquitination and degradation, providing an additional layer of control (evidenced by increased caspase activity and apoptosis in cells or mice lacking BIRC6) (pmc.ncbi.nlm.nih.gov). Post-translational modifications of Casp3 (e.g. phosphorylation by protein kinase Akt or others) have also been reported to modulate its activity or susceptibility to activation in some contexts (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov)，though the dominant mode of control remains proteolytic processing and inhibitor binding. Summarily, Casp3’s molecular function is executioner protease activity – it irreversibly cleaves a wide range of cellular proteins once activated, an activity that is kept latent until the appropriate apoptotic signals are received.
Execution of Apoptosis: Caspase-3’s most prominent role is in mediating the execution phase of apoptosis. Both major apoptotic pathways converge on Casp3 activation (pmc.ncbi.nlm.nih.gov), making it essential for the orderly dismantling of cells. In the extrinsic pathway, ligand binding to death receptors (e.g. Fas, TNF receptor) activates caspase-8, which directly cleaves procaspase-3 (and -7), thereby initiating the execution phase (pmc.ncbi.nlm.nih.gov). In the intrinsic pathway, cellular stress or developmental cues lead to mitochondrial outer membrane permeabilization and release of cytochrome c, which together with Apaf-1 and caspase-9 forms the apoptosome; caspase-9 then proteolyzes procaspase-3 (pmc.ncbi.nlm.nih.gov). Active Casp3 proceeds to cleave critical intracellular targets to carry out apoptosis. For example, Casp3 cleaves PARP1, halting DNA repair and trapping the cell in a death trajectory (pmc.ncbi.nlm.nih.gov). It cleaves ICAD, liberating CAD to fragment chromosomal DNA into nucleosomal units (the biochemical hallmark of apoptosis). It also cleaves nuclear lamin proteins, causing nuclear structure collapse, and cytoskeletal and adhesion proteins (like ROCK1, gelsolin, and desmoglein-2), leading to membrane blebbing and cell detachment (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Through cleavage of proteins like Xkr8 (a lipid scramblase) and other Xk-related family members, Casp3 triggers the externalization of phosphatidylserine on the cell surface – an “eat-me” signal that facilitates phagocytic uptake of the dying cell (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). All these events are coordinated to ensure the apoptotic cell is neatly disassembled and removed without leakage of harmful contents. Experimentally, Casp3 is often indispensable for these processes: genetic ablation of Casp3 in mice results in cells that undergo initiation of apoptosis but fail to complete the demolition stage effectively (e.g. they show reduced DNA fragmentation and persisting cellular structures) (pmc.ncbi.nlm.nih.gov). In vivo, Casp3-driven apoptosis is crucial for processes like digit separation, elimination of autoreactive immune cells, and neuron pruning during development. Indeed, developmental programmed cell death relies on Casp3: mice lacking Casp3 in certain genetic backgrounds exhibit ,e.g., aberrant brain development with hyperplasia and disorganized neuronal layering due to impaired apoptosis in neural progenitors (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This underscores that Casp3’s core biological process is apoptotic execution, necessary for normal development and tissue homeostasis.
Immune and Inflammatory Regulation: Although apoptosis is often considered immunologically “silent,” Caspase-3 has significant impacts on immune signaling. A striking example is its role in modulating type-I interferon (IFN) responses during cell death. Casp3 (and caspase-7) can cleave central proteins of the antiviral innate immune pathway – specifically the DNA sensor cGAS, the MAVS adaptor on mitochondria, and the transcription factor IRF3 – thereby inactivating these pathways and preventing an excessive IFN response as cells undergo apoptosis (pubmed.ncbi.nlm.nih.gov). Ning et al. (2019) demonstrated that in human cells activated caspase-3 cleaves cGAS, MAVS, and IRF3, and in Casp3-deficient murine cells there is a failure to shut off IFN production (pubmed.ncbi.nlm.nih.gov). As a result, Casp3^-/- mice showed elevated baseline IFN levels and were more resistant to viral infections, indicating that apoptotic caspases normally suppress antiviral cytokine production (pubmed.ncbi.nlm.nih.gov). This suggests Casp3 helps maintain immune homeostasis by ensuring that apoptotic cell clearance does not trigger autoimmune or inflammatory reactions. Another facet of Casp3’s immune role is its ability to process cytokines: Casp3 can cleave pro-IL-1β and pro-IL-18 (the pro-inflammatory cytokines classically matured by caspase-1). Casp3’s cut on IL-18 has been shown to be inactivating under some conditions (trimming it in a way that prevents signalling), which may further dampen inflammation (www.nature.com). Intriguingly, a recent study found that a shorter form of IL-18 generated by Casp3 cleavage can actually mobilize NK cells to fight tumors (www.nature.com), reflecting a nuanced regulatory role. Moreover, Casp3 is intimately involved in the apoptosis of immune cells themselves – for instance, during negative selection in the thymus (eliminating self-reactive T cells) or during contraction of immune responses, Casp3 executes the death of these lymphocytes. Phenotypically, Casp3 knockout mice show dysregulation in certain immune cell populations (for example, altered T and B cell homeostasis has been reported) due to cells surviving when they should be deleted (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Thus, Casp3 contributes to immune system processes both by culling cells and by biochemical crosstalk with inflammatory signaling.
Pyroptosis and Pro-inflammatory Cell Death: Apart from apoptosis, Caspase-3 can also drive pyroptosis, a lytic form of programmed cell death, under specific circumstances. Pyroptosis is typically mediated by inflammatory caspases (caspase-1/11 in mice) through cleavage of Gasdermin D, but Casp3 provides an alternative pathway via Gasdermin E (GSDME). In cells that express GSDME, Casp3 cleavage of GSDME’s inhibitory domain produces a pore-forming N-terminal fragment that perforates the plasma membrane, causing cell swelling and lysis (pmc.ncbi.nlm.nih.gov). This Casp3/GSDME axis effectively switches a would-be apoptotic event into a pyroptotic one, often accompanied by release of pro-inflammatory contents (e.g. HMGB1, IL-1 family cytokines) (pmc.ncbi.nlm.nih.gov). Wang et al. (2017) first showed that certain chemotherapy drugs kill cancer cells through Casp3-mediated GSDME activation, leading to pyroptosis rather than apoptosis (pmc.ncbi.nlm.nih.gov). Subsequent studies in 2020–2023 have revealed Casp3/GSDME-induced pyroptosis plays important roles in various contexts: it has been implicated in anti-tumor immunity (dying tumor cells releasing signals to attract immune cells) and in pathological conditions like sepsis and tissue injury where heightened inflammation occurs (pubmed.ncbi.nlm.nih.gov). For example, Jiao et al. (2023) highlight that Casp3/GSDME-mediated pyroptosis is a significant pathway in sepsis, proposing it as a therapeutic target in hyperinflammatory diseases (pubmed.ncbi.nlm.nih.gov). It’s important to note that GSDME is not ubiquitously expressed; thus, this pyroptotic outcome for Casp3 is context-dependent (e.g. high in some tumors, certain tissues). In Mus musculus, the Gsdme gene is functional (also known as DFNA5 in humans), and Casp3-driven pyroptosis has been observed in mouse models of chemotherapy and inflammatory injury (pmc.ncbi.nlm.nih.gov). Therefore, while Casp3’s default role leads to apoptotic cell death, in GSDME-positive environments it can participate in pyroptotic, pro-inflammatory death, bridging apoptosis and inflammation.
Neuronal Roles – Development and Synaptic Remodeling: Caspase-3 plays a critical role in neuronal development by removing excess neurons and sculpting neural circuits. During embryogenesis and early postnatal development, waves of Casp3-mediated apoptosis eliminate neurons that fail to integrate properly into circuits. As mentioned, Casp3-null mice in certain strains suffer brain overgrowth, ectopic neurons, and perinatal lethality due to insufficient developmental apoptosis in the CNS (pmc.ncbi.nlm.nih.gov). Beyond this developmental pruning, there is growing evidence that Casp3 has sub-lethal functions in mature neurons, particularly in synaptic plasticity and remodeling. Low levels of Casp3 activity have been detected in neurons undergoing adaptive changes without overt cell death. For instance, localized Casp3 activation is required for activity-dependent synapse elimination in the visual system: in a 2025 study, Yu et al. demonstrated that knocking out Casp3 in mice prevented microglia from engulfing weak synapses during circuit refinement, indicating Casp3 activity in neurons acts as a tag for synapse removal (elifesciences.org) (elifesciences.org). In hippocampal neurons, mild Casp3 activation has been linked to forms of long-term depression (LTD) and dendritic pruning – Jo et al. (2011) showed that suppression of LTP (long-term potentiation) and induction of LTD can require Casp3 activity, likely via cleavage of specific synaptic proteins (elifesciences.org). Additionally, aberrant Casp3 activation is implicated in neurodegenerative disease models: e.g., D’Amelio et al. (2011) reported early synaptic dysfunction in an Alzheimer’s model correlated with Casp3 activation in neurons (elifesciences.org). Mechanistically, Casp3 can cleave substrates like Akt kinase in dendrites, which leads to AMPA receptor internalization and synapse weakening (observed in LTD paradigms) (pmc.ncbi.nlm.nih.gov). Thus, synaptic remodeling and plasticity are influenced by Casp3 as a signaling protease, independent of killing the neuron. These non-apoptotic neural roles are usually tightly restricted in space and time, to avoid triggering full apoptosis. However, they underline Casp3’s versatility: it not only eliminates neurons wholesale during development, but also fine-tunes synaptic connections in the adult brain.
Cell Differentiation and Tissue Remodeling: Apart from its death-dealing functions, Casp3 has been implicated in the regulation of differentiation in multiple systems. In several contexts, a transient activation of Casp3 occurs without causing cell death but instead promotes a change in cell state. One well-characterized example is in muscle regeneration: Dick et al. (2015) found that activation of Casp3 in muscle satellite cells (muscle stem cells) is required to trigger their differentiation into muscle fibers (pubmed.ncbi.nlm.nih.gov). Casp3 directly cleaves the transcription factor Pax7, which is a master regulator of satellite cell self-renewal; cleavage of Pax7 by Casp3 inactivates it, thereby pushing the cells out of the stem-like state and allowing myogenic differentiation to proceed (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). In Pax7 cleavage-site mutant mice or when Casp3 is chemically inhibited, satellite cells fail to differentiate properly and muscle regeneration is impaired, demonstrating a non-apoptotic role for Casp3 in tissue repair (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). Similar phenomena have been observed in other lineages: during erythroid differentiation, Casp3 cleaves certain RNA-binding proteins to facilitate maturation of red blood cells (pmc.ncbi.nlm.nih.gov); during lens fiber cell differentiation, caspases (including Casp3) are activated to remove the nucleus and organelles of lens cells in a non-lethal manner (the cells survive as anucleate lens fibers). Casp3 has also been associated with regulating the cell cycle in progenitor cells – for instance, cleaving cell-cycle inhibitors or regulators to bias cells towards cycle exit and differentiation (pmc.ncbi.nlm.nih.gov). These sub-apoptotic roles typically involve careful control of Casp3 activity (partial activation or spatial confinement). They highlight that Casp3’s biological process involvement isn’t strictly limited to executing cell death: it can also act as a switch in cell-fate decisions and morphogenesis. Nonetheless, such roles are context-specific and often intersect with apoptotic pathways (sometimes termed “pre-apoptotic” signaling).
In summary, Casp3 is centrally involved in programmed cell death (apoptosis), with broad downstream effects on development and homeostasis. It also partakes in inflammatory regulation (via pyroptosis and cytokine/interferon modulation), in neuronal circuit refinement and function, and in certain differentiation programs. Each of these roles is supported by experimental evidence, particularly from gene knockout studies and biochemical analyses in mice. However, the strength of evidence and physiological relevance can vary, as discussed below.
Subcellular Localization: Caspase-3 is predominantly a cytosolic protein. In healthy cells, the procaspase-3 is found diffusely in the cytosol and also, notably, within the mitochondrial intermembrane space (pmc.ncbi.nlm.nih.gov). Mancini et al. (1998) showed that a fraction of procaspase-3 resides inside mitochondria, which may facilitate efficient coupling of mitochondrial apoptotic signals to Casp3 activation (pmc.ncbi.nlm.nih.gov). There is also evidence for a low level of nuclear localization of procaspase-3 in some cell types: for example, studies in lymphoid cells detected constitutive presence of procaspase-3 in the nucleus (often colocalized with its substrate ICAD) (pmc.ncbi.nlm.nih.gov). This suggests Casp3 is poised in multiple compartments. Upon apoptotic stimulation, active (cleaved) Casp3 has been observed initially in the cytoplasm and then rapidly accumulating in the nucleus (pmc.ncbi.nlm.nih.gov). This translocation allows Casp3 to access nuclear substrates like ICAD, PARP1, and lamins to execute nuclear dismantling. In apoptotic cells, cleaved Casp3 is commonly detected in both cytosol and nucleus, consistent with its role in globally cleaving targets throughout the cell. Casp3 does not have a membrane-targeting domain and lacks signal peptides, so it is generally excluded from organelles like the endoplasmic reticulum or secretory pathway. However, because some procaspase-3 is in the mitochondrial intermembrane space, once mitochondria rupture (during apoptosis) that Casp3 is released into the cytosol, potentially providing a burst of local activity (pmc.ncbi.nlm.nih.gov). Casp3 is not typically secreted (unlike inflammatory caspases, which can be released in inflammasomes), so its action is cell-intrinsic. For GO annotation, the well-supported localizations for mouse Casp3 are cytosol, cytoplasm (including centrosomal and perinuclear regions as reported in some cells), and nucleus (particularly during apoptosis). Additionally, by virtue of being in the mitochondrial intermembrane space, Casp3 could be annotated to mitochondria, though this subfraction’s functional significance is to augment intrinsic pathway signaling (pmc.ncbi.nlm.nih.gov). No stable presence of Casp3 on the plasma membrane or extracellular space has been noted, in line with it functioning inside cells.
Protein Complexes and Interactions: In its active form, Casp3 exists as a homodimer of heterodimers (p17/p12)_2, but this form is not known to be part of large stable holoenzymes – rather, it diffuses and cleaves substrates. That said, Casp3 does engage in several important molecular interactions and transient complexes:
Apoptosome: Caspase-3 is downstream of the Apaf-1/cytochrome c/caspase-9 apoptosome complex. While Casp3 is not a component of the apoptosome, it rapidly associates upon activation. Caspase-9 within the apoptosome cleaves procaspase-3 that is recruited to the vicinity. Thus, one can consider Casp3 as functionally linked to the apoptosome, and it might be co-immunoprecipitated as part of the post-activation complex. The apoptosome and Casp3 together propagate the intrinsic apoptosis signal (pmc.ncbi.nlm.nih.gov).
Death-Inducing Signaling Complex (DISC): In extrinsic apoptosis, Casp3 is again not a direct component of the DISC (which contains Fas/TNFR, FADD, procaspase-8, etc.), but active caspase-8 from the DISC cleaves procaspase-3 in proximity. Casp3 can briefly interact with components like caspase-8 during this handoff. In some cases, caspase-8 might first activate caspase-3 which then feedback cleaves additional caspase-8 molecules, forming a transient amplification complex.
IAP Complexes: A crucial regulatory complex involving Casp3 is with Inhibitor of Apoptosis Proteins. XIAP (BIRC4) binds caspase-3 in a binary complex – the BIR2 domain of XIAP plus its linker region binds across the Casp3 dimer interface, inserting into the active site cleft of Casp3 (pmc.ncbi.nlm.nih.gov). This steric inhibition prevents Casp3 from cleaving substrates. Structural and biochemical studies (e.g. Scott et al., 2005) detail how XIAP’s linker occupies the substrate-binding groove of Casp3 (pmc.ncbi.nlm.nih.gov). In cells, Casp3–XIAP complexes are common immediately after Casp3 activation, until Smac/DIABLO is released from mitochondria to displace XIAP. BIRC6 (Bruce) is another anti-apoptotic protein that interacts with Casp3. BIRC6 is a 528 kDa ubiquitin-conjugating enzyme/IAP hybrid; it has been shown to bind procaspase-3 and possibly active Casp3, sequestering it and tagging it for ubiquitination (pmc.ncbi.nlm.nih.gov). For instance, Birc6 mutant mouse embryos exhibited elevated caspase-3 activity and excessive cell death, indicating that the BIRC6–caspase-3 interaction normally restrains caspase-3 (pmc.ncbi.nlm.nih.gov). Thus Casp3 can be part of a complex with IAPs in resting cells (procaspase-3–BIRC6) or in recently activated cells (caspase-3–XIAP).
Caspase Cascades: Casp3 also transiently interacts with other caspases during activation. For example, caspase-3 can form a complex with caspase-9 when caspase-9 cleaves it, or Casp3 can dimerize with caspase-7 under certain conditions (heterodimer formation, although primarily it functions as homodimer). In a broader sense, Casp3 is part of the executioner caspase complex (caspase-3, -6, -7) that often co-localize and share substrates in apoptotic cells, but there isn’t a stable ternary complex – rather, they act in parallel and can compensate for each other to some degree (pmc.ncbi.nlm.nih.gov).
Substrate Complexes: As an enzyme, Casp3 binds briefly to its substrates during cleavage. Some cleavage events occur in specific subcellular locales, e.g., Casp3 cleaving gelsolin at the plasma membrane to promote blebbing, or Casp3 cleaving Akt1 at synapses during LTD (pmc.ncbi.nlm.nih.gov). These could be considered micro-complexes of Casp3 with a target protein at a location, sometimes scaffolded by other molecules. For instance, Casp3’s cleavage of Xkr8 at the membrane might involve a momentary complex on the inner leaflet of the plasma membrane (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). However, such interactions are transient and typically not captured as stable complexes suitable for GO “protein complex” annotation.
In summary, Casp3 is largely a soluble cytosolic/nuclear enzyme that can shuttle between cytoplasm and nucleus upon activation. It does not reside in membranes or organelle structures (aside from the intramitochondrial pool of procaspase). It operates within higher-order signaling assemblies like the apoptosome only transiently. The most well-defined stable binding partnerships of Casp3 are with its inhibitors (IAPs), which form inhibitory complexes to regulate Casp3’s activity. These interactions and localizations are strongly supported by biochemical fractionation, confocal microscopy, and structural studies (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov), providing confidence in annotating Casp3 to compartments like cytosol, mitochondrion, nucleus and to protein binding functions like IAP binding.
Core Functions vs. Context-Specific Roles: Caspase-3’s core functions – as an executioner of apoptosis – are firmly established and should form the backbone of its GO annotations. These include Molecular Function terms like cysteine-type endopeptidase activity and Biological Process terms such as execution phase of apoptosis (and child terms like intrinsic apoptotic signaling pathway and extrinsic apoptotic signaling pathway, where Casp3 acts downstream) (pmc.ncbi.nlm.nih.gov). Also well-supported is Casp3’s role in developmental programmed cell death, given clear phenotypes in mouse knockouts showing failure of proper developmental apoptosis (pmc.ncbi.nlm.nih.gov). Annotations to Cellular Component for cytosol and nucleus are low-risk, as multiple studies confirm Casp3 localization in those compartments (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These core annotations reflect ubiquitous, conserved functions of Casp3 and are unlikely to change with new data.
However, Casp3’s pleiotropy means it has been implicated in many processes beyond canonical apoptosis, and curators should carefully evaluate which of these warrant direct annotation. Some reported roles might be secondary consequences of apoptosis rather than independent functions. For example, Casp3 knockout mice show altered T-cell and B-cell homeostasis (presumably because apoptosis is required for removing excess immune cells) (pmc.ncbi.nlm.nih.gov). While it could be annotated to “regulation of lymphocyte homeostasis”, this is essentially via its apoptotic role. Curators should ensure that such process annotations are backed by direct evidence that Casp3 is mechanistically involved, and not merely that Casp3^-/- mice have more cells (an indirect phenotype). In this case, “apoptotic process involved in T cell homeostasis” might be more precise than broadly stating “T cell homeostasis.”
Similarly, Casp3 influences cell cycle and proliferation by killing cells or cleaving cell-cycle regulators during apoptosis. Annotations like “negative regulation of cell proliferation” could apply (since Casp3-mediated apoptosis curtails cell numbers), but this might overlap with the apoptosis terms. Unless there is evidence of Casp3 directly modulating the cell cycle in a non-lethal context, such annotations should be used with caution. Svandova et al. (2024) note that caspases (including Casp3) can target pathways beyond apoptosis, such as cell proliferation and differentiation (pmc.ncbi.nlm.nih.gov), but these functions are context-dependent and often subtle.
Context-Specific Roles: New research has expanded Casp3’s functional repertoire, but not all of these findings are universally applicable. For instance, Casp3’s role in synaptic plasticity and elimination is supported by robust studies in the visual system and hippocampus (elifesciences.org) (elifesciences.org). It may be appropriate to annotate Casp3 to processes like synapse pruning or long-term synaptic depression in the nervous system. Yet, these are highly cell-type specific. If GO has terms such as “axon pruning” or “synapse elimination in developmental growth cone remodeling,” Casp3 could be linked with an evidence code from the eLife 2025 study (IMP from mutant phenotype) (elifesciences.org). The risk is that such annotations might be over-generalized. In a GO context, one might add “caspase-3 involved in synapse elimination (IMP)” with a taxon constraint to mouse, and perhaps a comment about context (e.g. activity-dependent pruning in visual thalamus). This ensures that the annotation reflects a specific biological scenario rather than a universal function of Casp3.
Another example is Casp3 in muscle differentiation: the PNAS 2015 study provides strong evidence that Casp3 activity is required for muscle stem cell differentiation (via Pax7 cleavage) (pubmed.ncbi.nlm.nih.gov). This justifies an annotation to “positive regulation of muscle cell differentiation” or “skeletal muscle regeneration.” Yet, curators should note this is a non-apoptotic role where Casp3 is briefly active without causing cell death. It’s a bona fide function (with mechanistic basis) in muscle biology, so it can be included, but with the understanding that it’s context-specific (satellite cells post-injury). One could annotate Casp3 with “proteolysis involved in cell differentiation” or similar, referencing that study. The risk of omitting such roles is missing important biology, but the risk of including them is potentially implying Casp3 always does this – which it doesn’t (in most other cell types, Casp3 activation = death, not differentiation). Thus, annotations should be as specific as possible (e.g., regulation of myoblast differentiation with evidence from that experiment).
Pyroptosis and Cytokine Processing: Casp3’s role in pyroptosis via GSDME is now well-supported by multiple studies (pmc.ncbi.nlm.nih.gov). It would be reasonable to annotate Casp3 to “pyroptosis” or “gasdermin-mediated programmed cell death” with appropriate evidence, perhaps with a qualifier that it’s observed in cells expressing GSDME. The risk here is minimal, as the literature consensus since 2017 acknowledges caspase-3/GSDME pyroptosis in both human and mouse cells (pmc.ncbi.nlm.nih.gov). However, curators should avoid conflating this with caspase-1 mediated pyroptosis – it might be useful to specify “caspase-3-dependent pyroptosis” in a free-text comment. For cytokine maturation, Casp3 cleavage of IL-1β and IL-18 is documented, but this is not the primary pathway for these cytokines. GO has specific terms for “interleukin-1 beta maturation”. Casp3 could be annotated as a protease that participates in an alternative IL-18 processing pathway (www.nature.com), but that might be considered a bit peripheral. The UniProt entry notes IL-18 inactivation by Casp3 (“by similarity”), indicating it’s not strongly experimentally shown in mouse yet. It may be safer to hold off annotating Casp3 to IL-18 processing until more direct evidence in mice is published (the 2025 Nature Immunology study in tumors suggests a functional outcome, but one might wait for confirmation). Over-extension in this area could mislead if Casp3 is thought to be a routine IL-18 activator (which it is not in normal inflammasome responses).
Pleiotropy and Cautions: Because Casp3 is such a central protease, perturbations can produce wide-ranging phenotypes that tempt broad GO annotations. One should consider whether Casp3 is directly executing a process or if the process is a downstream effect of apoptosis. For example, an annotation like “axon guidance” would be inappropriate even if Casp3 knockout mice have neuron wiring defects – the direct role is in axon pruning via apoptosis, not guidance cues. Another example: Casp3-deficient mice reportedly have a modest resistance to certain infections and reduced severity of experimental autoimmune encephalomyelitis (EAE) due to higher IFN levels (pubmed.ncbi.nlm.nih.gov). While one could annotate “negative regulation of type I interferon production” to Casp3, it’s important to note this is a consequence of Casp3’s cleavage of cGAS/IRF3 (pubmed.ncbi.nlm.nih.gov). Given the strong mechanistic basis, this particular annotation is actually justified (with IMP from the Mol Cell 2019 study). But care must be taken: such immunomodulatory annotations should be clearly supported by specific experiments (e.g. Casp3^-/- vs WT comparisons showing differential cytokine responses) to avoid speculative links.
In GO revision, it’s advisable to separate core annotations from context-specific ones. Core annotations (apoptosis, executioner caspase activity, cytosol/nucleus localization) carry essentially no controversy. Contextual annotations (synaptic plasticity, muscle regeneration, innate immune regulation, pyroptosis) should be tagged with the evidence type and perhaps a note indicating the context (which GO allows via annotation extensions or notes). This will help users of GO understand that, for instance, Casp3 is not generally causing pyroptosis in all cells, but does so in the presence of GSDME (an annotation extension could even specify acts_in_presence_of Gsdme if such formalism existed).
Finally, curators should monitor ongoing research. Casp3’s newly discovered roles – especially non-apoptotic ones – are an active area. For instance, evidence for Casp3 in learning and memory processes is growing (elifesciences.org), but we’d await consensus before adding a term like “memory consolidation” to Casp3. The annotation strategy should prioritize well-reproduced functions and use high-quality, recent references for any new roles. By balancing inclusivity of new findings with caution against one-off results, the GO annotations for Casp3 will remain accurate and informative.
Svandová et al., Apoptosis, 2024 (June 2, 2024): “Exploring caspase functions in mouse models.” – Comprehensive review of caspase knockout phenotypes and functions. Summarizes Casp3 as a ubiquitous executioner caspase with broad substrates, essential for developmental apoptosis (strain-specific Casp3^-/- phenotypes in brain) and also highlights non-apoptotic roles in differentiation, proliferation, and immunomodulation (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). (DOI: 10.1007/s10495-024-01976-z)
Ning et al., Molecular Cell, 2019 (Apr 4, 2019): “Apoptotic caspases suppress type I interferon production via cleavage of cGAS, MAVS, and IRF3.” – Identified caspase-3 (in human cells) and caspase-7 (in mice) as key negative regulators of cytosolic DNA/RNA sensing pathways. Showed that activated Casp3 cleaves antiviral signaling proteins, dampening IFN-β output during apoptosis (pubmed.ncbi.nlm.nih.gov). Casp3^-/- mice exhibited heightened IFN and virus resistance, linking Casp3 to immune homeostasis (pubmed.ncbi.nlm.nih.gov). (DOI: 10.1016/j.molcel.2019.02.013)
Bhat et al., Int. J. Biol. Macromolecules, 2023 (Jul 1, 2023): “The pyroptotic role of caspase-3/GSDME signaling pathway among various cancers: A review.” – Recent review detailing how caspase-3 cleavage of Gasdermin E can induce pyroptotic cell death. Discusses evidence across cancer types that Casp3/GSDME activation leads to inflammatory cell lysis, with implications for cancer therapy and immune response (pubmed.ncbi.nlm.nih.gov). Highlights the concept of Casp3 as a switch between apoptosis and pyroptosis depending on cellular context. (DOI: 10.1016/j.ijbiomac.2023.124832)
Wang et al., Nature, 2017 (July 6, 2017): “Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin.” – Seminal study that first demonstrated caspase-3 can drive pyroptosis. Showed that certain chemotherapeutic agents activate Casp3, which cleaves Gasdermin E to form membrane pores, causing pyroptosis in cancer cells (pmc.ncbi.nlm.nih.gov). Provided a mechanistic link between apoptotic pathways and inflammatory death, explaining chemotherapy-induced tumor cell immunogenicity. (DOI: 10.1038/nature22393)
Yu & Gutu et al., eLife, 2025 (Oct 18, 2024 preprint; Jun 10, 2025 final): “Activity-dependent synapse elimination requires caspase-3 activation.” – Cutting-edge research in neuroscience showing that Casp3 is necessary for developmental synaptic pruning. In Casp3 KO mice, microglia failed to eliminate weaker synapses in the visual thalamus, resulting in improper circuit refinement (elifesciences.org). Demonstrated localized Casp3 activation at synapses following activity blockade and linked it to engulfment signals (likely via phosphatidylserine exposure on synapses). (eLife 13: e101779, 2025.)
Dick et al., PNAS, 2015 (Sep 22, 2015): “Caspase 3 cleavage of Pax7 inhibits self-renewal of satellite cells.” – Provided direct evidence of Casp3 in a differentiation context. Showed that Casp3 is transiently activated in muscle satellite cells after injury, cleaving the Pax7 transcription factor (pubmed.ncbi.nlm.nih.gov). This cleavage drives satellite cells out of quiescence into differentiation, and blocking Casp3 activity impeded muscle regeneration (pubmed.ncbi.nlm.nih.gov). Highlights a non-apoptotic role for Casp3 in tissue regeneration. (PMID: 26372956, PMCID: PMC4586837)
Suzuki et al., J. Biol. Chem., 2014 (Oct 31, 2014): “Exposure of phosphatidylserine by Xk-related protein family members during apoptosis.” – Investigated how apoptotic cells expose “eat-me” signals. Found that Caspase-3/7 directly cleave Xkr8, Xkr4, Xkr9 membrane proteins at conserved caspase sites, activating these scramblases (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This established the mechanism by which Casp3 causes phosphatidylserine exposure on dying cell surfaces to promote phagocytosis. (JBC 289(44):30257–67)
Scott et al., EMBO J., 2005 (Jan 13, 2005): “XIAP inhibits caspase-3 and -7 using two binding sites.” – Structural and biochemical analysis of the Casp3–XIAP interaction. Revealed that XIAP’s BIR2 domain and adjacent linker bind caspase-3, blocking its catalytic pocket (pmc.ncbi.nlm.nih.gov). Mutational studies showed this interaction is crucial for XIAP’s inhibition of apoptosis. This is a key reference for understanding caspase regulation by IAP complexes. (PMCID: PMC548652)
Each of these sources provides valuable insights: from broad reviews of caspase function to specific experimental findings on Casp3’s roles in apoptosis, immunity, neural development, and beyond. They underpin the annotations and statements made in this report, ensuring that the information is both current and grounded in experimental evidence.